Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by propionibacterium acnes

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Eishi, Yoshinobu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CLARITHROMYCIN; DOXYCYCLINE; HOST FACTOR; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 2; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

ANALYSIS; ANTIBIOTIC THERAPY; BACTERIAL GENOME; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOPSY; CARBOXY TERMINAL SEQUENCE; CORTICOSTEROID THERAPY; ESCHERICHIA COLI; EXPERIMENTAL MODEL; GRANULOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYCOBACTERIUM PARATUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARATUBERCULOSIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROPIONIBACTERIUM ACNES; PROPIONIBACTERIUM GRANULOSUM; RANDOM AMPLIFIED POLYMORPHIC DNA; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SARCOIDOSIS; ANIMAL; ARTICLE; CELL STRAIN HEK293; DISEASE MODEL; GENETICS; GRAM POSITIVE INFECTION; HYPERSENSITIVITY; LUNG; LYMPH NODE; MICROBIOLOGY; MOUSE; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE; COMPLICATION; HEK293 CELL LINE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HEK293 CELLS; HUMANS; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG; LYMPH NODES; MICE; PROPIONIBACTERIUM ACNES; REAL-TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS;

EID: 84880143711     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/935289     Document Type: Review

References (73)

1. Newman L. S., Rose C. S., Maier L. A., Sarcoidosis. The New England Journal of Medicine 1997 336 17 1224 1234 2-s2.0-0030940381 10.1056/ NEJM199704243361706
2. Hunninghake G. W., Costabel U., Ando M., Baughman R., Cordier J. F., du Bois R., Eklund A., Kitaichi M., Lynch J., Rizzato G., Rose C., Selroos O., Semenzato G., Sharma O. P., ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasculitis and Diffuse Lung Disease 1999 16 2 149 173 2-s2.0-0032881310
3. Baughman R. P., Lower E. E., du Bois R. M., Sarcoidosis. The Lancet 2003 361 9363 1111 1118 2-s2.0-0037471855 10.1016/S0140-6736(03)12888-7
4. Newman L. S., Rose C. S., Bresnitz E. A., Rossman M. D., Barnard J., Frederick M., Terrin M. L., Weinberger S. E., Moller D. R., McLennan G., Hunninghake G., DePalo L., Baughman R. P., Iannuzzi M. C., Judson M. A., Knatterud G. L., Thompson B. W., Teirstein A. S., Yeager H., Johns C. J., Rabin D. L., Rybicki B. A., Cherniack R., A case control etiologic study of sarcoidosis: environmental and occupational risk factors. American Journal of Respiratory and Critical Care Medicine 2004 170 12 1324 1330 2-s2.0-10644294658 10.1164/rccm.200402-249OC
5. McGrath D. S., Goh N., Foley P. J., du Bois R. M., Sarcoidosis: genes and microbes-soil or seed? Sarcoidosis Vasculitis and Diffuse Lung Diseases 2001 18 2 149 164 2-s2.0-0034951238
6. du Bois R. M., Goh N., McGrath D., Cullinan P., Is there a role for microorganisms in the pathogenesis of sarcoidosis? Journal of Internal Medicine 2003 253 1 4 17 2-s2.0-0037238323 10.1046/j.1365-2796.2003.01073.x
7. Drake W. P., Newman L. S., Mycobacterial antigens may be important in sarcoidosis pathogenesis. Current Opinion in Pulmonary Medicine 2006 12 5 359 363 2-s2.0-33748161826 10.1097/01.mcp.0000239554.01068.94
8. Eishi Y., Suga M., Ishige I., Kobayashi D., Yamada T., Takemura T., Takizawa T., Koike M., Kudoh S., Costabel U., Guzman J., Rizzato G., Gambacorta M., du Bois R., Nicholson A. G., Sharma O. P., Ando M., Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. Journal of Clinical Microbiology 2002 40 1 198 204 2-s2.0-0036135791 10.1128/JCM.40.1.198-204.2002
9. Brownell I., Ramírez-Valle F., Sanchez M., Prystowsky S., Evidence for mycobacteria in sarcoidosis. American Journal of Respiratory Cell and Molecular Biology 2011 45 5 899 905 10.1165/rcmb.2010-0433TR
10. Drake W. P., Dhason M. S., Nadaf M., Shepherd B. E., Vadivelu S., Hajizadeh R., Newman L. S., Kalams S. A., Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infection and Immunity 2007 75 1 527 530 2-s2.0-33846019267 10.1128/IAI.00732-06
11. Ebe Y., Ikushima S., Yamaguchi T., Kohno K., Azuma A., Sato K., Ishige I., Usui Y., Takemura T., Eishi Y., Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2000 17 3 256 265 2-s2.0-0033770698
12. Oswald-Richter K. A., Beachboard D. C., Seeley E. H., Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. Journal of Clinical Immunology 2012 32 5 1129 1140 10.1007/s10875-012-9700-5
13. Zumla A., James D. G., Granulomatous infections: etiology and classification. Clinical Infectious Diseases 1996 23 1 146 158 2-s2.0-19244362559
14. Homma J. Y., Abe C., Chosa H., Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Japanese Journal of Experimental Medicine 1978 48 3 251 255 2-s2.0-0018170934
15. Abe C., Iwai K., Mikami R., Hosoda Y., Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Series A 1984 256 4 541 547 2-s2.0-0021281415
16. Conron M., du Bois R. M., Immunological mechanisms in sarcoidosis. Clinical and Experimental Allergy 2001 31 4 543 554 2-s2.0-0035725549 10.1046/j.1365-2222.2001.01116.x
17. Agostini C., Meneghin A., Semenzato G., T-lymphocytes and cytokines in sarcoidosis. Current Opinion in Pulmonary Medicine 2002 8 5 435 440 2-s2.0-0036320837
18. Ishige I., Eishi Y., Takemura T., Kobayashi I., Nakata K., Tanaka I., Nagaoka S., Iwai K., Watanabe K., Takizawa T., Koike M., Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2005 22 1 33 42 2-s2.0-20144389191
19. Furukawa A., Uchida K., Ishige Y., Ishige I., Kobayashi I., Takemura T., Yokoyama T., Iwai K., Watanabe K., Shimizu S., Ishida N., Suzuki Y., Suzuki T., Yamada T., Ito T., Eishi Y., Characterization of Propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism. Microbial Pathogenesis 2009 46 2 80 87 2-s2.0-58549103083 10.1016/j.micpath.2008.10.013
20. Cue D. R., Cleary P. P., High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infection and Immunity 1997 65 7 2759 2764 2-s2.0-0030908268
21. Fidler H. M., Rook G. A., Johnson N. M., McFadden J., Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. British Medical Journal 1993 306 6877 546 549 2-s2.0-0027404396
22. Popper H. H., Winter E., Höfler G., DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. American Journal of Clinical Pathology 1994 101 6 738 741 2-s2.0-0028363675
23. Saboor S. A., Johnson M. N., McFadden J., Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. The Lancet 1992 339 8800 1012 1015 2-s2.0-0026603016 10.1016/0140-6736(92)90535-B
24. Bocart D., Lecossier D., de Lassence A., Valeyre D., Battesti J. P., Hance A. J., A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. American Review of Respiratory Disease 1992 145 5 1142 1148 2-s2.0-0026794680
25. Richter E., Greinert U., Kirsten D., Rüsch-Gerdes S., Schlüter C., Duchrow M., Galle J., Magnussen H., Schlaak M., Flad H. D., Gerdes J., Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. American Journal of Respiratory and Critical Care Medicine 1996 153 1 375 380 2-s2.0-9044243406
26. Vokurka M., Lecossier D., du Bois R. M., Wallaert B., Kambouchner M., Tazi A., Hance A. J., Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1997 156 3, part 1 1000 1003 2-s2.0-0030870121
27. Ishige I., Usui Y., Takemura T., Eishi Y., Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. The Lancet 1999 354 9173 120 123 2-s2.0-0033542902 10.1016/S0140-6736(98)12310-3
28. Yamada T., Eishi Y., Ikeda S., Ishige I., Suzuki T., Takemura T., Takizawa T., Koike M., In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. Journal of Pathology 2002 198 4 541 547 2-s2.0-0036899742 10.1002/path.1243
29. Negi M., Takemura T., Guzman J., Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Modern Pathology 2012 25 9 1284 1297 10.1038/modpathol.2012.80
30. Boyd J. F., Valentine J. C., Unidentified yellow bodies in human lymph-nodes. Journal of Pathology 1970 102 1 58 60 2-s2.0-0014844047
31. Doyle W. F., Brahman H. D., Burgess J. H., The nature of yellow brown bodies in peritoneal lymph nodes. Histochemical and electron microscopic evaluation of these bodies in a case of suspected sarcoidosis. Archives of Pathology and Laboratory Medicine 1973 96 5 320 326 2-s2.0-0015815461
32. Moscovic E. A., Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathology Annual 1978 13 part 2 69 164 2-s2.0-17944390350
33. Siltzbach L. E., The Kveim test in sarcoidosis. A study of 750 patients. The Journal of the American Medical Association 1961 178 476 482 2-s2.0-0001682517
34. Hunninghake G. W., Crystal R. G., Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. The New England Journal of Medicine 1981 305 8 429 434 2-s2.0-0019510394
35. Moller D. R., Forman J. D., Liu M. C., Noble P. W., Greenlee B. M., Vyas P., Holden D. A., Forrester J. M., Lazarus A., Wysocka M., Trinchieri G., Karp C., Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. Journal of Immunology 1996 156 12 4952 4960 2-s2.0-15844421725
36. Furusawa H., Suzuki Y., Miyazaki Y., Inase N., Eishi Y., Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis. Respiratory Investigation 2012 50 3 104 109 10.1016/j.resinv.2012.07.001
37. Nakata Y., Ejiri T., Kishi T., Mori Y., Hioka T., Kataoka M., Ohnoshi T., Kimura I., Alveolar lymphocyte proliferation induced by Propionibacterium acnes in sarcoidosis patients. Acta Medica Okayama 1986 40 5 257 264 2-s2.0-0022793733
38. Mori Y., Nakata Y., Kataoka M., Ejiri T., Hioka T., Maeda T., Hosoya S., Ohnoshi T., Kimura I., Interleukin-2 production and receptor expression of alveolar lymphocytes stimulated by Propionibacterium acnes in sarcoidosis. Nihon Kyobu Shikkan Gakkai Zasshi 1989 27 1 42 50 2-s2.0-0024351350
39. Hiramatsu J. I., Kataoka M., Nakata Y., Okazaki K., Tada S., Tanimoto M., Eishi Y., Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2003 20 3 197 203 2-s2.0-0242331679
40. Ogura Y., Bonen D. K., Inohara N., Nicolae D. L., Chen F. F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R. H., Achkar J. P., Brant S. R., Bayless T. M., Kirschner B. S., Hanauer S. B., Nũez G., Cho J. H., A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 411 6837 603 606 2-s2.0-0035978533 10.1038/35079114
41. Miceli-Richard C., Lesage S., Rybojad M., Prieur A. M., Manouvrier-Hanu S., Häfner R., Chamaillard M., Zouali H., Thomas G., Hugot J. P., CARD15 mutations in Blau syndrome. Nature Genetics 2001 29 1 19 20 2-s2.0-17944372335 10.1038/ng720
42. Kanazawa N., Okafuji I., Kambe N., Nishikomori R., Nakata-Hizume M., Nagai S., Fuji A., Yuasa T., Manki A., Sakurai Y., Nakajima M., Kobayashi H., Fujiwara I., Tsutsumi H., Utani A., Nishigori C., Heike T., Nakahata T., Miyachi Y., Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor- B activation: common genetic etiology with Blau syndrome. Blood 2005 105 3 1195 1197 2-s2.0-19944431022 10.1182/blood-2004-07-2972
43. Schürmann M., Valentonyte R., Hampe J., Müller-Quernheim J., Schwinger E., Schreiber S., CARD15 gene mutations in sarcoidosis. European Respiratory Journal 2003 22 5 748 754 2-s2.0-0242467576 10.1183/09031936.03. 00040602
44. Tanabe T., Ishige I., Suzuki Y., Aita Y., Furukawa A., Ishige Y., Uchida K., Suzuki T., Takemura T., Ikushima S., Oritsu M., Yokoyama T., Fujimoto Y., Fukase K., Inohara N., Nunez G., Eishi Y., Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochimica et Biophysica Acta 2006 1762 9 794 801 2-s2.0-33748748044 10.1016/j.bbadis.2006.07. 006
45. Nagy I., Pivarcsi A., Koreck A., Széll M., Urbán E., Kemény L., Distinct strains of Propionibacterium acnes induce selective human β -defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. Journal of Investigative Dermatology 2005 124 5 931 938 2-s2.0-18244368957 10.1111/j.0022-202X.2005.23705.x
46. Kalis C., Gumenscheimer M., Freudenberg N., Tchaptchet S., Fejer G., Heit A., Akira S., Galanos C., Freudenberg M. A., Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. Journal of Immunology 2005 174 7 4295 4300 2-s2.0-15444376617
47. Boughan P. K., Argent R. H., Body-Malapel M., Park J. H., Ewings K. E., Bowie A. G., Shao J. O., Cook S. J., Sorensen O. E., Manzo B. A., Inohara N., Klein N. J., Nuñez G., Atherton J. C., Bajaj-Elliott M., Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of β -defensins during Helicobacter pylori infection. Journal of Biological Chemistry 2006 281 17 11637 11648 2-s2.0-33744965671 10.1074/jbc.M510275200
48. Senaldi G., Yin S., Shaklee C. L., Piguet P. F., Mak T. W., Ulich T. R., Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. Journal of Immunology 1996 157 11 5022 5026 2-s2.0-0030459359
49. Tsuji H., Harada A., Mukaida N., Nakanuma Y., Bluethmann H., Kaneko S., Yamakawa K., Nakamura S. I., Kobayashi K. I., Matsushima K., Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infection and Immunity 1997 65 5 1892 1898 2-s2.0-0030987052
50. Yoneyama H., Matsuno K., Zhang Y., Murai M., Itakura M., Ishikawa S., Hasegawa G., Naito M., Asakura H., Matsushima K., Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. Journal of Experimental Medicine 2001 193 1 35 49 2-s2.0-0035182253 10.1084/jem.193.1.35
51. Yi E. S., Lee H., Suh Y. K., Tang W., Qi M., Yin S., Remick D. G., Ulich T. R., Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. American Journal of Pathology 1996 149 4 1303 1312 2-s2.0-0029840756
52. Ichiyasu H., Suga M., Iyonaga K., Ando M., Role of monocyte chemoattractant protein-1 in Propionibacterium acnes -induced pulmonary granulomatosis. Microscopy Research and Technique 2001 53 4 288 297 2-s2.0-0035872933 10.1002/jemt.1095
53. Minami J., Eishi Y., Ishige Y., Kobayashi I., Ishige I., Kobayashi D., Ando N., Uchida K., Ikeda S., Sorimachi N., Karasuyama H., Takemura T., Takizawa T., Koike M., Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes. Journal of Medical and Dental Sciences 2003 50 4 265 274 2-s2.0-17144472666
54. Swanborg R. H., Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunological Reviews 2001 184 129 135 2-s2.0-0035707638 10.1034/j.1600-065x.2001.1840112.x
55. Goulvestre C., Batteux F., Charreire J., Chemokines modulate experimental autoimmune thyroiditis through attraction of autoreactive or regulatory T cells. European Journal of Immunology 2002 32 12 3435 3442
56. Teuscher C., Hickey W. F., Grafer C. M., Tung K. S. K., A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/C mice. Journal of Immunology 1998 160 6 2751 2756 2-s2.0-0032521291
57. Nishiwaki T., Yoneyama H., Eishi Y., Matsuo N., Tatsumi K., Kimura H., Kuriyama T., Matsushima K., Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. American Journal of Pathology 2004 165 2 631 639 2-s2.0-3242751222
58. Casadevall A., Pirofski L. A., Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infection and Immunity 1999 67 8 3703 3713 2-s2.0-0032765322
59. Iwai K., Takemura T., Kitaichi M., Kawabata Y., Matsui Y., Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathologica Japonica 1993 43 7-8 377 385 2-s2.0-0027199576
60. Lin P. L., Flynn J. L., Understanding latent tuberculosis: a moving target. Journal of Immunology 2010 185 1 15 22 2-s2.0-77956216718 10.4049/jimmunol.0903856
61. Tufariello J. M., Chan J., Flynn J. L., Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infectious Diseases 2003 3 9 578 590 2-s2.0-0042863345 10.1016/S1473-3099(03)00741-2
62. Keane J., Gershon S., Wise R. P., Mirabile-Levens E., Kasznica J., Schwieterman W. D., Siegel J. N., Braun M. M., Tuberculosis associated with infliximab, a tumor necrosis factor α -neutralizing agent. The New England Journal of Medicine 2001 345 15 1098 1104 2-s2.0-0035846326 10.1056/NEJMoa011110
63. Gifre L., Ruiz-Esquide V., Xaubet A., Gómez-Puerta J. A., Hernández M. V., Sanmartí R., Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review. Archivos de Bronconeumologia 2011 47 4 208 212 2-s2.0-79954633243 10.1016/j.arbres.2010.05.011
64. Keane J., TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology 2005 44 6 714 720 2-s2.0-24944529247 10.1093/rheumatology/keh567
65. Gottlieb J. E., Israel H. L., Steiner R. M., Triolo J., Patrick H., Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy. Chest 1997 111 3 623 631 2-s2.0-0030900530
66. Bachelez H., Senet P., Cadranel J., Kaoukhov A., Dubertret L., The use of tetracyclines for the treatment of sarcoidosis. Archives of Dermatology 2001 137 1 69 73 2-s2.0-0035143344
67. Baba K., Yamaguchi E., Matsui S., Niwa S., Onoe K., Yagi T., Hattori T., Ozawa H., Hara K., A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2006 23 1 78 79 2-s2.0-33747480245
68. Park D. J. J., Woog J. J., Pulido J. S., Cameron J. D., Minocycline for the treatment of ocular and ocular adnexal sarcoidosis. Archives of Ophthalmology 2007 125 5 705 709 2-s2.0-34248551956 10.1001/archopht.125.5.705
69. Miyazaki E., Ando M., Fukami T., Nureki S. I., Eishi Y., Kumamoto T., Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clinical Rheumatology 2008 27 9 1195 1197 2-s2.0-48449098777 10.1007/s10067-008-0903-3
70. Esterly N. B., Koransky J. S., Furey N. L., Trevisan M., Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Archives of Dermatology 1984 120 10 1308 1313 2-s2.0-0021160015 10.1001/archderm.120.10. 1308
71. Kloppenburg M., Verweij C. L., Miltenburg A. M. M., Verhoeven A. J., Daha M. R., Dijkmans B. A. C., Breedveld F. C., The influence of tetracyclines on T cell activation. Clinical and Experimental Immunology 1995 102 3 635 641 2-s2.0-0029559043
72. Webster G. F., Toso S. M., Hegemann L., Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin: involvement of protein kinase C. Archives of Dermatology 1994 130 6 748 752 2-s2.0-0028238002 10.1001/archderm.130.6.748
73. Marshall T. G., Marshall F. E., Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmunity Reviews 2004 3 4 295 300 2-s2.0-3042736014 10.1016/j.autrev.2003.10.001